--2024/Q4-- / 13.858B--
--2024/Q3-- / 12.180B--
Apr 30, 20242024/Q18.768B / 8.930B--
Feb 6, 20242023/Q49.353B / 8.971B--
US Stock MarketDetailed Quotes
LLY Eli Lilly and Co
- 952.740
- -1.430-0.15%
Close Aug 23 16:00 ET
- 949.900
- -2.840-0.30%
Post 20:02 ET
905.51BMarket Cap117.33P/E (TTM)
960.500High943.110Low2.06MVolume955.440Open954.170Pre Close1.96BTurnover0.22%Turnover Ratio164.27P/E (Static)950.43MShares972.53052wk High66.77P/B903.47BFloat Cap513.10952wk Low4.86Dividend TTM948.29MShs Float972.530Historical High0.51%Div YieldTTM1.82%Amplitude5.287Historical Low950.939Avg Price1Lot Size
Eli Lilly and Co Key Stats
Eli Lilly and Co Q2 2024 Earnings Date
Highlights | Eli Lilly beat estimates and raised full-year earnings guidance, sending a surge of more than 10% in its share price in pre-market trading
Currency：USDAug 8, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 9.97B | 11.30B | +1.34B |
| Beat Est. | +19.92% | +35.98% | +13.40% |
| EPS | 2.72 | 3.28 | +0.56 |
| Beat Est. | +39.43% | +68.21% | +20.64% |
Analyst Rating
Aug 23, 2024
Eli Lilly and Co Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Eli Lilly and Co Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
